Stabilization of different conformational states of liver pyruvate kinase type L by the allosteric activators.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000494:Allosteric Regulation; D000818:Animals; D001665:Binding Sites; D002848:Chromatography, DEAE-Cellulose; D002852:Chromatography, Ion Exchange; D004355:Drug Stability; D004789:Enzyme Activation; D006358:Hot Temperature; D007531:Isoflurophate / Q000494:pharmacology*; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008274:Magnesium / Q000494:pharmacology*; D010728:Phosphoenolpyruvate / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology*; D011402:Pronase; D011485:Protein Binding; D011487:Protein Conformation; D011770:Pyruvate Kinase / Q000378:metabolism*; D051381:Rats
D007531:Isoflurophate; D000244:Adenosine Diphosphate; D010728:Phosphoenolpyruvate; D011770:Pyruvate Kinase; D011402:Pronase; D008274:Magnesium; D011188:Potassium